Hong Alexander T

Hong Alexander T, Lin Forest, Baxter Sally, Weinreb Robert N

Tirzepatide significantly reduced primary open-angle glaucoma, ocular hypertension, and glaucoma treatment risk in type 2 diabetes patients. This suggests a potential neuroprotective or pressure-lowering benefit, offering a novel therapeutic avenue for glaucoma management.

Hong Alexander T, Yang Eric J, Duong Andrew, Apolo Galo, Nguyen Van D, Xu Benjamin Y

AS-OCT biometrics, especially smaller AOD750, predict corneal endothelial contact with intracameral implants. This improves preoperative screening, identifying high-risk patients better than gonioscopy, enhancing surgical safety in glaucoma.